{"entity":{"id":"beth-devine","kind":"person","name":"Beth Devine","aka":[],"tldr":"Pharmacist-health economist serving as 2026-2027 President of ISPOR, the global society for health economics and outcomes research.","summary":"Beth Devine, PhD, PharmD, MBA, is President of ISPOR for the 2026-2027 term. Her academic work at the University of Washington focuses on comparative effectiveness research, health technology assessment and the use of real-world evidence in decision making, all of which shape how new oncology therapies are evaluated for value and reimbursement.","asOf":"2026-09-10","links":[{"label":"Society page","url":"https://www.ispor.org/about/board-of-directors"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Devine+EB%5BAuthor%5D"}],"tags":["leadership","health economics","health technology assessment"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["ispor"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":["journal-of-geriatric-oncology"],"dependsOn":[],"notes":[],"role":"President (2026-2027)","institutionId":"ispor","specialisms":["Health economics and outcomes research","Comparative effectiveness","Health technology assessment"],"profiles":[{"label":"Society page","url":"https://www.ispor.org/about/board-of-directors"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Devine+EB%5BAuthor%5D"}],"papers":[{"title":"Use of geriatric assessment in cancer clinical trials: A systematic review","journal":"Journal of Geriatric Oncology","year":2022,"doi":"10.1016/j.jgo.2022.04.014"}]},"route":"/people/beth-devine/","neighbours":{"institution":[{"id":"ispor","kind":"institution","name":"ISPOR (The Professional Society for Health Economics and Outcomes Research)","route":"/institutions/ispor/"}],"journal":[{"id":"journal-of-geriatric-oncology","kind":"journal","name":"Journal of geriatric oncology","route":"/journals/journal-of-geriatric-oncology/"}]}}